This video is featured in the 2024 ESMO Annual Meeting Insights Hub

2024 ESMO Annual Meeting Insights Hub
A

ESMO 2024 Insights: Nivo + Ipi ± ASTX727 in Anti-PD-1 Resistant Metastatic Melanoma - NIBIT-ML1 Ph2 Study

By 2024 ESMO Annual Meeting Insights Hub FEATURING Anna Maria Di Giacomo
By 2024 ESMO Annual Meeting Insights Hub FEATURING Anna Maria Di Giacomo
74 views
September 20, 2024
Comments 0
Login to view comments. Click here to Login

2024 ESMO Annual Meeting Insights Hub: Skin Videos

17:12

New

ESMO 2024 Summary: Long-Term Survival Outcomes in Advanced Melanoma …

2024 ESMO Annual Meeting Insights Hub

J. Hassel

12 views

·

2 weeks ago
08:45

New

ESMO 2024 Insights: Follow-Up Brain Imaging in Melanoma Patients Wit…

2024 ESMO Annual Meeting Insights Hub

I. Ozdamar

13 views

·

2 weeks ago
18:24

ESMO 2024 Summary: Neoadjuvant Immunotherapy as the Future of Melano…

2024 ESMO Annual Meeting Insights Hub

A. van Akkooi

56 views

·

1 month ago
View All

Recommended

17:50

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

1.9K views

·

7 months ago
24:14

Advances in the Treatment of Melanoma

Masterclasses in Dermatology

D. Fisher

808 views

·

8 months ago
35:23

ASCO® 2024 Summary: "My Personal Highlights in Melanoma"

2024 ASCO® Annual Meeting Insights Hub

S. Patel

771 views

·

4 months ago
09:26

The NADINA Trial - A Paradigm Shift in Melanoma Treatment

Oncology Data Advisor

M. Hadfield

289 views

·

3 months ago
12:46

FDA Approval of Lifileucel for Unresectable or Metastatic Melanoma: …

Stanford Medicine

A. Betof Warner

1.0K views

·

8 months ago
22:58

The Role of Adjuvant IO vs. Targeted Therapy for BRAF V600-Mutant St…

Tarek Haykal

710 views

·

4 months ago
10:01

AAD 2024 Insights: The Latest Advances in the Treatment of Melanoma

AAD 2024

V. Sondak

639 views

·

8 months ago
11:05

ASCO® 2024 Summary: "Highlights in Early Stage, 1L Metastatic, and R…

2024 ASCO® Annual Meeting Insights Hub

D. Johnson

475 views

·

5 months ago
14:42

Optimal Treatment for BRAF-Mutated Metastatic Melanoma

Jeff Yorio

520 views

·

4 months ago
25:29

ASCO® 2024 Summary: "Insights in Melanoma"

2024 ASCO® Annual Meeting Insights Hub

O. Hamid

464 views

·

4 months ago
09:54

ASCO® 2024 Insights: "RELATIVITY-047 Trial 3-Year OS and MSS Outcome…

2024 ASCO® Annual Meeting Insights Hub

H. Tawbi

390 views

·

5 months ago
28:32

Checkpoint Inhibitors, Arthritis and Other Autoimmune Triggers

West Virginia State Rheumatology Society

J. Bustamante

413 views

·

4 months ago
09:33

ESMO 2024 Summary: Metastatic Melanoma Highlights

2024 ESMO Annual Meeting Insights Hub

C. Blank

197 views

·

1 month ago
18:28

NCCN Guidelines Updates for the Management of Cutaneous Melanoma: Ne…

Vanderbilt University Medical Center (VUMC)

D. Johnson

400 views

·

6 months ago
24:27

ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and Adjuva…

2024 ASCO® Annual Meeting Insights Hub

Z. Eroglu

326 views

·

4 months ago
11:27

ASCO® 2024 Summary: "Curing Stage IV Melanoma - Where Have We Been a…

2024 ASCO® Annual Meeting Insights Hub

P. Corrie

286 views

·

5 months ago
12:17

ESMO 2024 Summary: Key Metastatic and Neoadjuvant Melanoma Trials

2024 ESMO Annual Meeting Insights Hub

D. Johnson

178 views

·

1 month ago
08:41

ASCO® 2024 Insights: "NADINA Trial - Neoadjuvant Nivo + Ipi in Macro…

2024 ASCO® Annual Meeting Insights Hub

C. Blank

263 views

·

5 months ago
22:27

Developmental Therapeutics Highlights From ASCO® 2024

2024 ASCO® Annual Meeting Insights Hub

G. Sonpavde

533 views

·

4 months ago
20:07

New

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde

236 views

·

3 weeks ago
AUTOPLAY